Trainor Drew, Moeschler Susan, Pingree Matthew, Hoelzer Brian, Wang Zhen, Mauck William, Qu Wenchun
Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN, USA.
Department of Anesthesiology, Division of Pain Medicine, Mayo Clinic, Rochester, MN, USA.
J Pain Res. 2015 Oct 23;8:767-70. doi: 10.2147/JPR.S86777. eCollection 2015.
Chronic postherniorrhaphy groin pain (CPGP) is a debilitating condition, which is often refractory to conservative medical management. To our knowledge, there have been no studies directly comparing landmarked-based and ultrasound-guided approaches in this population.
To compare the effectiveness of landmark-based and ultrasound-guided ilioinguinal/iliohypogastric nerve blocks in the treatment of CPGP.
This is a retrospective chart review of patients who presented to our tertiary care pain medicine clinic with a diagnosis of CPGP. Inclusion criteria were the following: age >18 years, diagnosis of groin pain, and prior history of herniorrhaphy. Exclusion criteria included those who were seen for initial consultation but were lost to follow-up. Primary outcomes were 50% or greater reduction in pain on visual analog scale (VAS). Secondary outcomes were 30% or greater reduction in VAS pain score, changes in VAS pain scores, and reported complications.
A total of 36 patients were included in the study. Of them, 20 patients underwent the landmark-based and 16 underwent the ultrasound-guided techniques. There was no significant difference in baseline demographics. The average VAS score preinjection was 7.08 in the landmark-based and 7.0 in the ultrasound-guided groups (P=0.65). A total of 14 patients (70%) in the landmark-based and eleven patients (79%) in the ultrasound-guided groups experienced at least a 50% reduction in VAS scores. There was no statistically significant difference between the two groups (P=1.0), and no complications were noted. We also did not find a significant difference in terms of number of patients with 30% or greater reduction (P=0.71) and changes in VAS pain scores (P=0.64). No complications were reported in either group.
In our study, there was no statistically significant difference between the landmark-based and ultrasound-guided groups in terms of a reduction in VAS pain scores, and no complications were noted in either group.
疝修补术后慢性腹股沟疼痛(CPGP)是一种使人衰弱的病症,通常对保守药物治疗无效。据我们所知,尚无研究直接比较该人群中基于体表标志和超声引导的方法。
比较基于体表标志和超声引导的髂腹股沟/髂腹下神经阻滞治疗CPGP的有效性。
这是一项对到我们三级医疗疼痛医学诊所就诊且诊断为CPGP的患者的回顾性病历审查。纳入标准如下:年龄>18岁、腹股沟疼痛诊断以及既往疝修补病史。排除标准包括那些初诊后失访的患者。主要结局是视觉模拟量表(VAS)疼痛评分降低50%或更多。次要结局是VAS疼痛评分降低30%或更多、VAS疼痛评分的变化以及报告的并发症。
共有36例患者纳入研究。其中,20例患者接受了基于体表标志的技术,16例接受了超声引导技术。基线人口统计学特征无显著差异。基于体表标志组注射前平均VAS评分为7.08,超声引导组为7.0(P=0.65)。基于体表标志组共有14例患者(70%)、超声引导组有11例患者(79%)的VAS评分至少降低了50%。两组之间无统计学显著差异(P=1.0),且未观察到并发症。我们还发现,VAS评分降低30%或更多的患者数量(P=0.71)以及VAS疼痛评分的变化(P=0.64)方面也无显著差异。两组均未报告并发症。
在我们的研究中,基于体表标志组和超声引导组在VAS疼痛评分降低方面无统计学显著差异,且两组均未观察到并发症。